16.46

5.18% 0.81

After Hours: 16.61 0.15 +0.91%

10 X Genomics Inc (TXG)

Overview News Price History Option Chain Financials Discussions Forecast

10 X Genomics Inc stock is traded at $16.46, with a volume of 3.68M. It is up +5.18% in the last 24 hours and up +25.27% over the past month. 10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Previous Close:

$15.65

Open:

$16.2

24h Volume:

3.68M

Relative Volume:

1.37

Market Cap:

$1.88B

Revenue:

$631.73M

Net Income/Loss:

$-239.78M

P/E Ratio:

-8.1485

EPS:

-2.02

Net Cash Flow:

$-33.45M

1W Performance:

+0.67%

1M Performance:

+25.27%

6M Performance:

+81.28%

1Y Performance:

+23.57%

1-Day Range:

$16.11

$17.16

1-Week Range:

$15.12

$17.16

52-Week Range:

$6.78

$17.70

10 X Genomics Inc Stock (TXG) Company Profile

Name

10 X Genomics Inc

Sector

Healthcare (1132)

Industry

Health Information Services (52)

Phone

(925) 401-7300

Address

6230 STONERIDGE MALL ROAD, PLEASANTON, CA

Employee

1,306

Twitter

@10xgenomics

Next Earnings Date

2024-10-31

Latest SEC Filings

TXG's Discussions on Twitter

Compare TXG with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TXG 10 X Genomics Inc	16.46	1.98B	631.73M	-239.78M	-33.45M	-2.02
VEEV Veeva Systems Inc	270.50	44.75B	2.97B	809.93M	1.33B	4.8743
TEM Tempus Ai Inc	65.69	12.29B	803.32M	-709.10M	-212.68M	-7.8003
HQY Healthequity Inc	100.73	8.92B	1.15B	96.70M	-161.99M	1.09
DOCS Doximity Inc	46.42	9.04B	550.17M	201.35M	232.07M	1.00
WAY Waystar Holding Corp	34.79	6.66B	906.14M	-52.62M	89.62M	-0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-11-25	Initiated	Piper Sandler	Neutral
Feb-13-25	Downgrade	Leerink Partners	Outperform → Market Perform
Sep-03-24	Initiated	Leerink Partners	Outperform
Jul-22-24	Upgrade	Jefferies	Hold → Buy
Jul-18-24	Downgrade	JP Morgan	Overweight → Neutral
Jul-10-24	Downgrade	Deutsche Bank	Buy → Hold
Jun-27-24	Downgrade	Wolfe Research	Outperform → Peer Perform
Jun-25-24	Downgrade	Guggenheim	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Hold
May-01-24	Downgrade	TD Cowen	Buy → Hold
Dec-14-23	Initiated	Guggenheim	Buy
Dec-13-23	Initiated	Wolfe Research	Outperform
Dec-12-23	Upgrade	BofA Securities	Underperform → Neutral
Jul-05-23	Resumed	JP Morgan	Overweight
May-10-23	Initiated	Barclays	Overweight
Mar-31-23	Initiated	Stephens	Overweight
Feb-02-23	Initiated	UBS	Neutral
Dec-14-22	Initiated	Deutsche Bank	Buy
Aug-18-22	Downgrade	Goldman	Neutral → Sell
Jul-25-22	Initiated	Canaccord Genuity	Buy
Jul-15-22	Downgrade	BofA Securities	Neutral → Underperform
Jul-15-22	Downgrade	William Blair	Outperform → Mkt Perform
Oct-15-21	Resumed	Cowen	Outperform
Sep-14-21	Downgrade	BofA Securities	Buy → Neutral
Mar-15-21	Initiated	William Blair	Outperform
Dec-02-20	Initiated	Goldman	Neutral
Sep-09-20	Initiated	Morgan Stanley	Overweight
Jul-10-20	Initiated	Stifel	Buy
Mar-05-20	Initiated	Guggenheim	Buy
Jan-07-20	Initiated	Citigroup	Buy
Oct-07-19	Initiated	BofA/Merrill	Buy
Oct-07-19	Initiated	Cowen	Outperform
Oct-07-19	Initiated	JP Morgan	Overweight
Sep-24-19	Initiated	Evercore ISI	Outperform

View All

10 X Genomics Inc Stock (TXG) Latest News

07:08 AM

Spatial Biology Market Analysis and Forecast, 2025-2035: - GlobeNewswire

07:08 AM

Spatial Biology Market Analysis and Forecast, 2025-2035: Stellaromics, RareCyte, and 10x Genomics Drive Innovation and Funding Momentum - Yahoo Finance

07:08 AM

12:53 PM

How 10x Genomics Inc. (1KJ) stock trades pre earnings2025 Support & Resistance & Reliable Breakout Forecasts - newser.com

12:53 PM

Nov 19, 2025

Is 10x Genomics Inc. stock a buy before product launchesJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com

Nov 19, 2025

Nov 18, 2025

10x Genomics (Nasdaq: TXG) Xenium Powers ASTRA Atlas of 2,000 Asia-Pacific Tumor Samples - Stock Titan

Nov 18, 2025

Nov 16, 2025

10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - Nasdaq

Nov 16, 2025

10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN

Nov 16, 2025

Nov 15, 2025

10x Genomics Announces Chief Legal Officer Retirement - MSN

Nov 15, 2025

Nov 14, 2025

10x Genomics GC Who Led Rule Of Law Effort To Retire In '26 - Law360

Nov 14, 2025

There's Reason For Concern Over 10x Genomics, Inc.'s (NASDAQ:TXG) Massive 42% Price Jump - simplywall.st

Nov 14, 2025

10x Genomics, Inc. Announces Executive Changes, Effective January 1, 2026 - MarketScreener

Nov 14, 2025

10X Genomics Stock Soars 17.31%, Hits Intraday High of $15.26 - Markets Mojo

Nov 14, 2025

Nov 13, 2025

10x Genomics Inc Class A Earnings and Revenue – HAM:1KJ - TradingView

Nov 13, 2025

How 10x Genomics Inc. (1KJ) stock valuation compares with sectorChart Signals & Safe Entry Point Alerts - newser.com

Nov 13, 2025

Why 10x Genomics Inc. (1KJ) stock attracts wealthy investorsSell Signal & Verified Stock Trade Ideas - newser.com

Nov 13, 2025

10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025 - Eastern Progress

Nov 13, 2025

Nov 12, 2025

10x Genomics (TXG): Assessing Valuation After Strong Earnings, Upbeat Forecast and New Product Launch - Yahoo Finance

Nov 12, 2025

Nov 11, 2025

Piper Sandler Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq

Nov 11, 2025

10x Genomics to Participate in the Wolfe Research Healthcare Con - GuruFocus

Nov 11, 2025

10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat - Insider Monkey

Nov 11, 2025

Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance

Nov 11, 2025

Is 10x Genomics Inc. stock ready for a breakoutWeekly Market Summary & AI Enhanced Trading Signals - newser.com

Nov 11, 2025

Can a trend reversal in 10x Genomics Inc. lead to recovery2025 Volume Leaders & Real-Time Volume Analysis - newser.com

Nov 11, 2025

Nov 10, 2025

10x Genomics stock hits 52-week high at 17.26 USD - Investing.com

Nov 10, 2025

10x Genomics, Inc.'s (NASDAQ:TXG) 33% Price Boost Is Out Of Tune With Revenues - 富途牛牛

Nov 10, 2025

Nov 09, 2025

Research Alert: CFRA Keeps Hold Rating On Shares Of 10x Genomics, Inc. - 富途牛牛

Nov 09, 2025

Nov 08, 2025

10X Genomics Tops Q3 Estimates And Cuts Losses - Finimize

Nov 08, 2025

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Eledon Pharmaceuticals (ELDN) and AMN Healthcare Services (AMN) - The Globe and Mail

Nov 08, 2025

10x Genomics (TXG): How Fresh Results and New Guidance Are Shaping Its Valuation - simplywall.st

Nov 08, 2025

10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 08, 2025

Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - Nasdaq

Nov 08, 2025

Nov 07, 2025

JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq

Nov 07, 2025

TXG: Canaccord Genuity Raises Price Target for 10x Genomics to $19 | TXG Stock News - GuruFocus

Nov 07, 2025

GUIDANCE: (TXG) 10x Genomics, Inc. Expects Q4 Revenue Range $154.0M$158.0M - 富途牛牛

Nov 07, 2025

10x Genomics, Inc. SEC 10-Q Report - TradingView

Nov 07, 2025

10x Genomics: Q3 Earnings Snapshot - CT Insider

Nov 07, 2025

Is 10x Genomics Inc. stock supported by strong fundamentalsPortfolio Risk Report & Safe Entry Trade Signal Reports - newser.com

Nov 07, 2025